Search
Validating DIGItal biomarkers for better personalized treatment of Parkinson’s Disease
Validating DIGItal biomarkers for better personalized treatment of Parkinson’s Disease
Fraunhofer SCAI
Sitemap
Objectives
Work packages
Data
Partners
Publications
FAQ
More
Where am I?
Homepage
FAQ
FAQ
WP 5: Ethical, Legal and Social Aspects of AI and DMs
Expand all
Close all
Which digital personal data does the consortium process?
Who are controller and processors in the project?
Can the consortium instruct Amazon Web Services (AWS) to store personal data on its behalf, taking into account Schrems cases?
On which lawful basis are the processing activities carried out in the project? And after the project if digital biomarkers could be used in medical practice?
Is there a duty to keep the data collected during the project after the end of this project? Which data must be kept?
What are the obligations of the consortium when the PD patients exercise their rights?